Manufacturer of Pazopanib

Pazopanib(Pazopanib) is an oral anti-tumor drug used to treat malignant tumors such as renal cell carcinoma and soft tissue sarcoma. Overseas it is usually provided by Novartis Pharmaceuticals, Novartis Europe Pharmaceuticals and GlaxoSmithKline. Pazopanibis classified as a tyrosine kinase inhibitor, and typically it is sold asVotrient orpazopanib hydrochloride.

Pazopanib, a drug used to fight metastasis, inhibits endothelial cell production and fibroblast proliferation, according to experimental studies, and it has the unique ability to bind to proteins that confer resistance in tumor cell growth. This is accomplished by cutting off the blood supply to metastatic cells, stopping the production of tumor cells. To achieve the desired effect and avoid any risks, it is recommended to take the 200mg tablet on an empty stomach, especially one hour before or two hours after meals. If any doses are missed, it is important to maintain a 12-hour difference between doses.

PazopanibThe original drug has been launched in China and has entered the scope of Class B medical insurance, but reimbursement is limited to patients who meet the indications. The price of each box may be around 3,000 yuan. The price of pazopanib original drug specifications200mg*30 tablets marketed overseas may be around 1,000 RMB per box (the price may fluctuate due to exchange rates). There are also pazopanib generic drugs produced in other countries. The price of 200mg*30 tablets produced by Bangladesh pharmaceutical factory may be around 500 yuan per box (the price may fluctuate due to the exchange rate), which is cheaper. The pharmaceutical ingredients of generic drugs are basically the same as those of domestic and foreign original drugs.